|
Last Updated: Nov 18, 2006 - 12:32:53 PM |
Latest Research
:
Cancer
:
Renal Cell Carcinoma
Renal cancer related to deficiency in exposure to sunlight
Using newly available data on worldwide cancer incidence to map cancer rates in relation to proximity to the equator, researchers at the Moores Cancer Center at University of California, San Diego (UCSD) have shown a clear association between deficiency in exposure to sunlight, specifically ultraviolet B (UVB), and kidney cancer.
Sep 19, 2006 - 2:53:00 PM
Latest Research
:
Cancer
:
Renal Cell Carcinoma
Sunitinib malate more effective than standard cytokine treatment in metastatic renal cell carcinoma (mRCC)
According to a new study, the drug sunitinib malate is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC).
Jun 5, 2006 - 4:34:00 PM
Latest Research
:
Cancer
:
Renal Cell Carcinoma
Bayer wins positive response for cancer drug
Bayer AG said Friday that the company and its US partner Onyx Pharmaceuticals Inc have received a positive response from European officials to their drug to treat kidney cancer.
Apr 30, 2006 - 7:25:00 PM
Latest Research
:
Cancer
:
Renal Cell Carcinoma
Imatinib mesylate is not likely to be effective for patients with high grade renal cell carcinoma
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma -- the most aggressive kidney cancer. Results of the study are published in the January issue of The Journal of Urology.
Dec 22, 2005 - 5:04:00 AM
<< prev
next >>
|
